Skip to content

The European Union Falsified Medicines Directive (FMD) is designed to protect public health by securing the pharmaceutical supply chain against counterfeit medicines. It’s a rigorous set of rules that pharmaceutical companies operating in Europe need to abide by, and at Sharp we can help.

Our comprehensive serialisation service can help you meet the criteria demanded by the FMD by making your products fully traceable and trackable through their supply chain.

We’re able to aggregate serial numbers for up to five levels of packaging in multiple formats, from the cavities of our blister packs through to the pallets they ship in, so you’ll always be able to identify where your products are – and where they came from.

Related Resources

Sharp has acquired a stake in Berkshire Sterile Manufacturing. This deal will allow us to better meet our clients' needs in regards to packaging and labeling. For more information, check out our press release: https://berkshiresterilemanufacturing.com/2020/08/05/sharp-acquires-stake-in-berkshire-sterile-manufacturing/

Member news: @Sharp_Services acquires stake in @BerkshireSM https://www.sharpservices.com/resources/sharp-acquires-stake-in-berkshire-sterile-manufacturing/

We're delighted to announce that Sharp has purchased a minority 25% ownership in @BerkshireSM with the support of @UDGHealthcare, extending the existing preferred partner agreement that has been in place since 2018.

Read more here: https://lnkd.in/em3Fqzs